Brain Health
8 productsNeuroprotective and cognitive function research peptides.
8 products
Scientific Overview & Research Target
Peptide research in cognitive function and neuroprotection investigates compounds that interact with neurotrophic factor expression, neurotransmitter balance, social-behavior neuropeptide signaling, and mitochondrial resilience in neural tissue.
Studies suggest that combined intranasal Semax and Selank formulations support BDNF-related plasticity and GABA/serotonin pathway balance, oxytocin modulates affiliative and stress-response circuitry, and SS-31 is explored for mitochondrial membrane efficiency relevant to neuronal bioenergetics.
Looking for detailed research protocols?
Review our comprehensive scientific guide on brain health peptide pathways.
Cellular Mechanisms & Study Pathways
BDNF Upregulation
Research suggests Semax, a synthetic ACTH(4-10) fragment, rapidly upregulates brain-derived neurotrophic factor and nerve growth factor mRNA, enhancing synaptic plasticity, neurite outgrowth, and cAMP/CREB signaling.
GABAergic Modulation
Studies indicate Selank, a tuftsin analog, enhances GABAergic inhibitory activity while balancing serotonin and dopamine pathways, reducing anxiety-driven neural hyperactivity without cognitive impairment.
Social & Stress Circuit Modulation
Research suggests oxytocin influences hypothalamic and limbic circuits involved in affiliative behavior, emotional processing, and autonomic stress responses—areas of active investigation in neurobehavioral models.
Neuronal Mitochondrial Support
Studies indicate SS-31 targets mitochondrial membranes and electron transport efficiency; preclinical work examines implications for oxidative balance and ATP supply in metabolically demanding tissues including the CNS.
Key Research Compounds
NAD+ 500mg
Selank 10mg
Semax 10mg
MOTS-C 40mg
NAD 1000mg
Oxytocin 5mg
Selank/Semax Nasal Spray 60mg
SS-31 50mg
Frequently Asked Questions
What neuroprotective pathways are studied in cognitive research peptides?
Brain health research investigates neurotrophic factor expression (such as BDNF upregulation by Semax), GABAergic pathways (Selank), social-emotional neuropeptide circuitry (Oxytocin), and neuronal mitochondrial efficiency (SS-31).
Are cognitive research peptides approved for treating memory loss or anxiety?
No. None of these compounds are approved by the FDA or other regulatory bodies to treat, prevent, or diagnose cognitive decline, anxiety, or neurological diseases.